Advanced understanding of Staphylococcus aureus infections in Europe - Surgical Site infections
- Conditions
- Surgical Site Infections10004018
- Registration Number
- NL-OMON47402
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 900
1. The subject is 18 years of age or older.
2. The subject is undergoing 1 or more of the 10 surgical procedures listed in this protocol. The surgical procedure is planned or unplanned.
3. The subject has been screened for S. aureus colonization from three body regions: nose, throat, and perineum within 30 days prior to surgery, and based on the preoperative S. aureus colonization status of the subject, the subject qualifies for enrolment in the study cohort.
4. Written informed consent has been obtained from the subject prior to enrollment in the study cohort.
1. Parallel participation in any experimental study of an anti-Staphylococcus preventive intervention.
2. An active diagnosis of a SSI as the reason for surgery.
3. Not able to comply with study procedures and follow-up based on Investigator judgment.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To assess the incidence of S. aureus SSI up to 90 days following surgery and<br /><br>its independent association with patient-related, pathogen-related and<br /><br>contextual factors.</p><br>
- Secondary Outcome Measures
Name Time Method